Press Releases from BellaSeno GmbH (8 total)
BellaSeno Initiates Scaffold Development Program for Tendon and Ligament Regener …
- Collaboration with Fraunhofer IZI further expanded
- Funding provided by Sächsische Aufbaubank
Leipzig, Germany, July 1, 2021 – BellaSeno GmbH, an ISO 13485-certified medtech company developing absorbable scaffolds using additive manufacturing technologies, today announced that the Company has initiated a program on tendon and ligament reconstruction funded by the State of Saxony´s Sächsische Aufbaubank (SAB). The program will be run in close collaboration with Fraunhofer Institute for Cell Therapy and Immunology…
BellaSeno Wins Prestigious German Innovation Award 2021
- Leading-edge Senella® soft tissue technology awarded for excellence in B2B / medical technologies
Leipzig, Germany, May 18, 2021 – BellaSeno GmbH, an ISO 13485-certified medtech company developing absorbable scaffolds using additive manufacturing technologies, today announced that the Company has received the German Innovation Award from the German Design Council for its Senella® technology in the category #W2 Excellence in Business to Business - Medical Technologies. BellaSeno has been chosen among…
BellaSeno Establishes GMP-Compliant High-Throughput Additive Manufacturing Facil …
- Seamless transition from R&D to commercial-scale additive manufacturing
- Leading-edge cleanroom, no-touch manufacturing
- GMP capabilities for internal and contract manufacturing
Leipzig, Germany, November 17, 2020 - BellaSeno GmbH, an ISO 13485-certified medtech company developing absorbable scaffolds using additive manufacturing technologies, today announced the establishment of a novel, leading-edge additive manufacturing facility for medical implants supported by the Fraunhofer Institute for Cell Therapy and Immunology IZI, Leipzig, Germany.
It is the one…
BellaSeno and Charite - Universitaetsmedizin Berlin Collaborate Under BMBF-Funde …
- Development of absorbable implants for the personalized treatment of bone defects in patients with diabetes
- BellaSeno responsible for high resolution, medical-grade scaffold manufacturing under ISO 13485
Leipzig, Germany, March 24, 2020 - BellaSeno GmbH, a company developing absorbable scaffolds using additive manufacturing technologies, today announced a collaboration with Charite - Universitaetsmedizin Berlin under the recently established SyMBoD consortium. Under the agreement, BellaSeno will design and manufacture personalized, 3D-printed, absorbable…
Evonik and BellaSeno partner to enable the launch of an innovative 3D printed br …
- 3D printed breast scaffolds to be made of RESOMER®
- Degradation of RESOMER® to match the growth of the patient’s own tissue for natural breasts
- Technology designed to improve quality of life for patients after breast reconstruction and augmentation
- Human clinical trials to commence later this year
Evonik, a global leader in biomaterials for implantable medical devices, and BellaSeno GmbH, a developer of 3D printed absorbable scaffolds, today announced the signing…
Novel Data on BellaSeno’s Biodegradable Breast Implants to Be Presented by Co- …
- Two presentations at the 50th Annual Conference of the German Society of Plastic, Reconstructive and Aesthetic Surgery (DGPRÄC)
- Recent publication in scientific journal Additive Manufacturing
Leipzig, Germany, September 19, 2019 - BellaSeno GmbH, a company developing absorbable implants using additive manufacturing technologies, today announced that its co-founder Dietmar W. Hutmacher will introduce BellaSeno’s novel approach for breast reconstruction using 3-D-printed scaffolds during the 50th Annual Conference of the German Society…
BellaSeno’s Design and Manufacturing Processes Fully ISO 13485 Certified
- Company transitions from research to manufacturing stage, raises an additional EUR 1 million to conduct clinical trial
- Among the first medtech companies worldwide to offer integrated contract manufacturing of additively produced implants under ISO standards
Leipzig, Germany, July 15, 2019 - BellaSeno GmbH, a company developing absorbable implants using additive manufacturing technology, today announced it obtained full ISO 13485 certification for its design and additive manufacturing processes, ranging from the…
BellaSeno Receives RegMedNet Award for Cultivating Excellence
- Leipzig-based start-up prepares for first clinical trial in 2019
Leipzig, Germany, December 06, 2018 - BellaSeno GmbH, a company developing absorbable implants using additive manufacturing technology, today announced it was awarded the 2018 Award for Cultivating Excellence by RegMedNet for its innovation, creativity, professionalism and investment in young professionals. BellaSeno won the public vote after five finalists were shortlisted by an expert jury. The award was established in 2017 to…
